| 炎症性肠病的药物治疗现状 |
| 投稿时间：2016-09-20 修订日期：2016-12-03 点此下载全文 |
| 引用本文：卞莹莹,王洁,李安,开国银,陆一鸣.炎症性肠病的药物治疗现状[J].药学实践杂志,2017,35(3):197~200,228 |
| 摘要点击次数: 1659 |
| 全文下载次数: 1684 |
|
| 基金项目:国家自然科学基金资助项目（30500093，81274162）；国家科技部"重大新药创制"专项（2009ZX09103-690）；上海市科委生物医药领域科技支撑项目（16431904400）；上海市教委科研创新项目（14ZZ077） |
|
| 中文摘要:炎症性肠病（inflammatory bowel disease，IBD）目前是消化系统疾病的研究热点之一，主要包括溃疡性结肠炎（ulcerative colitis，UC）和克罗恩病（Crohn's disease，CD），其发病机制尚未完全阐明，也尚无针对IBD的有效治疗药物。随着对IBD发病机制的深入研究，出现了一些新型药物和制剂。笔者就IBD及其药物治疗的研究现状作一简要综述。 |
| 中文关键词:炎症性肠病 溃疡性结肠炎 克罗恩病 药物治疗 |
| |
| The research status of the drug therapy for inflammatory bowel disease |
|
|
| Abstract:Research on the inflammatory bowel disease(IBD) is a hot topic in the field of digestive system disease. IBD mainly consists of ulcerative colitis(UC) and Crohn's disease(CD). The pathogenesis of IBD has not been fully understood. So far, there is no specific medication for IBD. A number of novel medicines and preparations have emerged with the research progress on the pathogenesis of IBD. The research status on IBD drug therapy is briefly reviewed in this paper. |
| keywords:inflammatory bowel disease ulcerative colitis Crohn's disease drug therapy |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
